Sanara MedTech (SMTI) to Release Quarterly Earnings on Tuesday

Sanara MedTech (NASDAQ:SMTI) is set to announce its earnings results after the market closes on Tuesday, November 12th. Investors that are interested in participating in the company’s conference call can do so using this link.

Sanara MedTech (NASDAQ:SMTI) last released its earnings results on Monday, August 12th. The company reported ($0.41) EPS for the quarter. Sanara MedTech had a negative return on equity of 15.17% and a negative net margin of 9.07%. The company had revenue of $20.16 million during the quarter.

Sanara MedTech Stock Down 0.4 %

NASDAQ SMTI traded down $0.14 during mid-day trading on Tuesday, reaching $33.31. The stock had a trading volume of 11,998 shares, compared to its average volume of 19,014. Sanara MedTech has a 1 year low of $26.00 and a 1 year high of $43.25. The company has a fifty day moving average price of $32.40 and a 200 day moving average price of $31.14. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.80 and a quick ratio of 1.49.

About Sanara MedTech

Sanara MedTech Inc, a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers.